AWC
MRNA icon

Adamsbrown Wealth Consultants’s Moderna MRNA Stock Holding History

Adamsbrown Wealth Consultants’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,171
Closed -$210K – 81
2022
Q4 		$210K Buy
+1,171
New +$191K 0.13% 71
2022
Q2 		– Sell
-2,545
Closed -$438K – 92
2022
Q1 		$438K Buy
2,545
+398
+19% +$67K 0.35% 50
2021
Q4 		$545K Buy
+2,147
New +$628K 0.49% 36

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adamsbrown Wealth Consultants's MRNA Position: Q1 2023 in Review

Adamsbrown Wealth Consultants sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,171 shares — an estimated $210K sold.

Adamsbrown Wealth Consultants first reported a position in MRNA in Q4 2021 and held it in 3 quarters. The position peaked at $545K in Q4 2021. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Adamsbrown Wealth Consultants reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Adamsbrown Wealth Consultants sold 1,171 Moderna shares in Q1 2023, an estimated $210K.
  • Adamsbrown Wealth Consultants first reported a position in Moderna in Q4 2021 and held it in 3 quarters.
  • Adamsbrown Wealth Consultants's Moderna position peaked at $545K in Q4 2021.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Adamsbrown Wealth Consultants's 13F filing for Q1 2023, filed 10 May 2023.